Tony P Tang
Inventor
Stats
- 5 US patents issued
- 44 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 5 US Patents Issued
- 44 US Applications Filed
- 163 Total Citation Count
- Apr 23, 2024 Most Recent Filing
- Jan 9, 2009 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
ARRAY BIOPHARMA, INC. | 2
2 4 2 1 3 1 | 2009
2011 2012 2014 2015 2016 2017 |
CELGENE CORPORATION | 1
| 2015
|
Genentech, Inc. | 1
1 2 2 2 1 | 2009
2011 2012 2014 2016 2017 |
Inventor Addresses
Address | Duration |
---|---|
BOULDER, CO, US | Oct 01, 20 - Dec 09, 21 |
Boudler, CO, US | Dec 04, 18 - Dec 04, 18 |
Boulder, CO, US | Mar 03, 11 - Dec 31, 24 |
San Diego, CA, US | Nov 23, 23 - Mar 28, 24 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 28 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 24 |
C07D: | HETEROCYCLIC COMPOUNDS | 44 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12180207 | 2024 | Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases | 0 |
2024/0309,020 | 2024 | KRAS G12D INHIBITORS | 0 |
11998545 | 2024 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | 0 |
11964989 | 2024 | KRas G12D inhibitors | 0 |
2024/0101,553 | 2024 | KRAS G12C INHIBITORS | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.